Suppression of mTOR Signaling by miR ‐302/367 Cluster in Breast Cancer Cells
Authors:
- 16 August 2025
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 39 (16) , e70943
Abstract
The mTOR signaling pathway is central in regulating key cellular functions, including cell cycle progression, protein synthesis, and glucose metabolism. Dysregulation of this pathway is a hallmark of many cancers. We previously demonstrated the multimodal tumor suppressive effects of the miR‐302/367 cluster. In this investigation, we explored the effects of exogenous overexpression of the miR‐302/367 cluster on mTOR signaling in malignant cells and assessed its direct targeting of pathway components. Bioinformatic analyses revealed PIK3CB, RRAGD, FNIP1, and FNIP2 as potential targets of miR‐302/367 involved in mTOR regulation. Dual‐luciferase reporter assays validated the direct interaction between the miR‐302/367 cluster with PIK3CB , RRAGD , and FNIP1 . Transfection of SK‐BR‐3 and MDA‐MB‐231 breast cancer cell lines with a vector expressing miR‐302/367 resulted in the downregulation of these three genes at the transcript level. Furthermore, the protein levels of FNIP1, RRAGD, and PIK3CB were also diminished in both cell lines. Additionally, cell proliferation was inhibited, and profiling of gene and protein expression indicated a downregulation of several other components of the mTOR pathway, suggesting a broad inhibitory effect of miR‐302/367 on mTOR signaling. These results reveal a novel molecular mechanism by which the miR‐302/367 cluster may exert tumor‐suppressive effects by modulating mTOR pathway activity at multiple levels in breast cancer cells, thereby suggesting its potential relevance for future therapeutic investigation in cancer treatment.Keywords
Funding Information
- Iran National Science Foundation (98023252)
- National Institute for Genetic Engineering and Biotechnology (970901‐I‐693)
This publication has 55 references indexed in Scilit:
- PIK3CB promotes oesophageal cancer proliferation through the PI3K/AKT/mTOR signalling axisCell Biology International, 2022
- A novel role for aspirin in enhancing the reprogramming function of miR‐302/367 cluster and breast tumor suppressionJournal of Cellular Biochemistry, 2022
- miR‐16 enhances miR‐302/367‐induced reprogramming and tumor suppression in breast cancer cellsIUBMB Life, 2020
- RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1Cancer Medicine, 2019
- Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathwayJournal of Cellular Physiology, 2019
- Emerging roles of microRNAs in regulating the mTOR signaling pathway during tumorigenesisJournal of Cellular Biochemistry, 2019
- Vitamin C counteracts miR‐302/367‐induced reprogramming of human breast cancer cells and restores their invasive and proliferative capacityJournal of Cellular Physiology, 2018
- Rheb signaling and tumorigenesis: mTORC1 and new horizonsInternational Journal of Cancer, 2015
- Expression of the miR‐302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypesInternational Journal of Cancer, 2015
- Regulation of androgen receptor transactivity and mTOR–S6 kinase pathway by Rheb in prostate cancer cell proliferationThe Prostate, 2010